Safi Biotherapeutics
Cambridge, Massachusetts, United States · Biotechnology, Health Care, Manufacturing
Safi Biotherapeutics is a developer of manufactured red blood cells (mRBCs) designed to serve as an alternative to donor blood transfusions. The company is focused on advancing bio-manufactured red blood cells with targeted immuno-phenotypes for various chronic transfusion indications. Launched in 2020, Safi is progressing the technology to demonstrate the feasibility of an allogeneic, stem-cell s
Key facts
- Headquarters
- Cambridge, Massachusetts, United States
- Employees
- 11
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- safi.bio
- Company page
Recent activity at Safi Biotherapeutics
Safi Biotherapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2024 | Seed | $5.0M |
Leadership
- Kyle Meetze, Senior Management Executive
- Doug Mcconnell
- Katie Glen, Process Development and Analytical Lead
- Tammy Mogford, Commercial Transition Director
Verified email and direct lines for Safi Biotherapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Safi Biotherapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Safi Biotherapeutics in the news
- Safi Biotherapeutics Inc. and DesiCorp Inc. Initiate Collaboration to Support Freeze-Drying of mRBCs - PR Newswire (Mar 31, 2026)
- Safi Biotherapeutics Awarded a $4.7 Million Extension by U.S. DoW to Advance Manufactured Red Blood Cells Toward First Clinical Trial - Yahoo Finance (Nov 03, 2026)
- Safi Biotherapeutics and ARMI | BioFabUSA Complete Successful Technical Transfer of Initial Clinical Scale 10L mRBC Production System - PR Newswire (Jan 08, 2026)
Companies similar to Safi Biotherapeutics
- African Medicines Agency · Biotechnology, Health Care, Manufacturing
- PanTera · Biotechnology, Health Care, Manufacturing
- Taicend Technology · Biotechnology, Health Care, Manufacturing
- GMP Manufacturing Ltd · Biotechnology, Health Care, Manufacturing
- Sophrosyne Technologies · Biotechnology, Health Care, Manufacturing
About Safi Biotherapeutics: questions and answers
What does Safi Biotherapeutics do?
Safi Biotherapeutics is a developer of manufactured red blood cells (mRBCs) designed to serve as an alternative to donor blood transfusions. The company is focused on advancing bio-manufactured red blood cells with targeted immuno-phenotypes for various chronic transfusion indications. Launched in 2020, Safi is progressing the technology to demonstrate the feasibility of an allogeneic, stem-cell s
Where is Safi Biotherapeutics headquartered?
Safi Biotherapeutics is headquartered in Cambridge, Massachusetts, United States.
How many employees does Safi Biotherapeutics have?
Safi Biotherapeutics has about 11 employees.
Has Safi Biotherapeutics raised funding?
Yes. Fundz has recorded 1 funding event for Safi Biotherapeutics. The most recent, Seed of $5.0M, was in Sep 2024.
What is the latest news on Safi Biotherapeutics?
On Nov 04, 2026, Safi Biotherapeutics secures a $4.7 million extension to advance manufactured red blood cells toward its first clinical trial.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy